$65M NIH grant propels U.W. translational research institute

The National Institutes of Health is giving translational device and diagnostics research at the University of Washington a $65 million shot in the arm. As The Seattle Times reports, the new 5-year grant will help the school's Institute of Translational Health Sciences run pilot projects, launch clinical trials and ultimately spin-off businesses centered around new devices and diagnostic tests. Other projects could center around new drugs, or even smartphone apps that help patients with particular conditions. One early success from the institute: The launch of a company centered around a device designed to deliver medication to a patient with a brain infection or disease. Story

Suggested Articles

Takeda tapped Roche’s Foundation Medicine to develop tissue- and blood-based companion diagnostic tests for its portfolio of lung cancer therapies.

Cellex has announced plans to develop a rapid coronavirus test that people can fully perform at home, from sample collection to result, using an app.

More than 20 states either don’t release or have incomplete data on the rapid antigen tests now considered key to containing the coronavirus.